Alarmins such as IL-25, IL-33 and TSLP function at the initial stages of the allergy cascade and are anticipated to have a more comprehensive impact on airway inflammation, potentially offer more effective asthma management than currently therapies (30, 48). This evidence concerns the gene IL25 and allergic disease.